PremiumPre-EarningsAXNX Earnings this Week: How Will it Perform? Axonics receives regulatory approval for rechargeable SNM System in Australia Axonics prevails in patent infringement lawsuit with Medtronic PremiumThe FlyAxonics shareholders approve merger with Boston Scientific Axonics provides update on inter partes review proceedings Medtronic moves for patent infringement litigation with Axonics to resume PremiumThe FlyBoston Scientific price target raised to $70 from $62 at Wells Fargo Axonics downgraded to Hold from Buy at Needham Axonics downgraded to Equal Weight from Overweight at Morgan Stanley 
